Genetics of Inflammatory Bowel Disease

Genetics of Inflammatory Bowel Disease

European Gastroenterology & Hepatology Review Volume4 Issue 2
Published: October 2009
dots

Crohn’s disease (CD) and ulcerative colitis (UC) are common chronic relapsing inflammatory disorders of the gastrointestinal tract characterised by a dysregulated mucosal immune response. Significant progress in the understanding of the pathogenesis of these two clinical entities has developed from studies of human genetics and genetically engineered animal models. The current working model of disease pathogenesis suggests that inflammatory bowel disease (IBD) results from a dysregulated immune response to intestinal flora in a genetically susceptible individual. This article focuses on the historical perspective of the elucidation of genetic susceptibility, the progression to the identification of susceptibility loci using genome scan within multiply affected families, leading to the discovery of NOD2/CARD15 as the first CD gene, and finally the recent landmark findings implicating more than 30 susceptibility genes using genome-wide association studies (GWAS).

Evidence of Genetic Susceptibility in Disease Pathogenesis
There are considerable epidemiological data that implicate genetic susceptibility in the pathogenesis of CD and UC. Most notably, these include the familial prevalence of IBD, concordance rates in twin pairs and ethnic differences in disease susceptibility. In fact, the studies of twin pairs have provided the strongest impetus towards further investigation of genetic susceptibility in IBD. Three studies have been carried out in Europe, including Tysk’s important review of the Swedish Twin Registry in 1988.1–3 The data from these studies, in Sweden, Denmark and the UK, combine to provide powerful evidence for the role of both genetic and environmental factors in disease susceptibility. The concordance rates for CD in monozygotic and dizygotic twin pairs from these studies are estimated to be 37 and 7%, respectively; in UC, the equivalent results are 10 and 3%, respectively. From these data, the co-efficient of heritability (an estimate of the proportion of susceptibility attributable to inherited factors alone) may be calculated. The derived co-efficient of heritability in CD is similar to the value calculated from twin studies carried out in insulin-dependent diabetes and multiple sclerosis, and in fact is stronger than in many other common complex diseases. The genetic contribution is clearly less strong in UC, but the concordance between monozygotic and dizygotic prevalence rates again argues for a genetic and perhaps a stronger relative environmental contribution to disease susceptibility in UC.




To read full article please click here

Keywords:
Inflammatory Bowel Disease, Crohn’s disease, Inflammatory Bowel Disease, inflammatory disorders,

Copyright® 2010 Business Briefings, Ltd. All rights reserved.
Touch Gastroenterology is for informational purposes and should not be considered medical advice, diagnosis or treatment recommendations.